Browse by category

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

The first patient has been treated in Nitinotes’ US Investigational Device Exemption (IDE) EASE Clinical Trial evaluating the EndoZip Automated Suturing System for endoscopic sleeve gastroplasty (ESG). The procedure was performed at Lenox Hill Hospital | Northwell Health in New York, NY, the trial's first activated US site. The EASE Clinical Trial is a prospective, multi-centre, randomised, two-arm, blinded pivotal study designed to evaluate the safety and effectiveness of th

Triple agonist retatrutide delivers average 71.2 lbs weight loss

23 hours ago

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

2 days ago

Corbus’ from Oral CB1 inverse agonist CRB-913 demonstrates favourable safety profile and emerging evidence of weight loss

2 days ago

Browse by category

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

Browse by tag

Triple agonist retatrutide delivers average 71.2 lbs weight loss

First patient treated in EASE clinical trial evaluating the EndoZip Automated Suturing System for ESG

Corbus’ from Oral CB1 inverse agonist CRB-913 demonstrates favourable safety profile and emerging evidence of weight loss

Back to Top